In a recent study published in Nature Medicine, researchers demonstrated the use of the foundational model Virchow for computational analysis of pathological reports, prediction of biomarkers, and identification of cells across multiple cancer types. Virchow’s pan-cancer model showed impressive accuracy, often outperforming clinical-grade models.
Wider use of high-dose hemodiafiltration may have benefits for kidney failure patients
Mortality in patients with kidney failure has been found to be 23% lower among those treated with high dose hemodiafiltration compared to those treated with